← Back to headlines
Singapore Biotech Mirxes Delays Results After Audit Issues
Singaporean biotech company Mirxes has postponed the release of its results in Hong Kong after an audit flagged several issues.
4 Apr, 11:45 — 4 Apr, 11:45
Sources
Showing 1 of 1 sources



